Tennessee Department of Health Investigates Cases of Botulism-Like Illness Linked to Cosmetic Injections

The Tennessee Department of Health (TDH) is working in collaboration with the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) to investigate a series of botulism-like illnesses linked to cosmetic injections. The concern arises from the use of counterfeit products or products with unclear origins being administered in non-medical settings such as homes or cosmetic spas.

Recently, TDH identified four patients who experienced botulism-like symptoms after receiving botulinum toxin injections for cosmetic purposes. Two of the patients required hospitalization, highlighting the seriousness of the situation. Similar cases have been reported in multiple states, with ongoing investigations pointing towards the use of counterfeit products.

Botulism is a rare and potentially fatal illness caused by a nerve toxin produced by certain bacteria. Symptoms can include blurred vision, drooping eyelids, slurred speech, difficulty swallowing, and muscle weakness. Prompt medical attention and specialized treatment are crucial in managing botulism cases.

TDH emphasizes the importance of receiving cosmetic injections from FDA-approved products administered by licensed providers in licensed settings. Healthcare providers are urged to inquire about recent cosmetic procedures in patients presenting with botulism-like symptoms. Suspected cases should be reported to TDH immediately.

The mission of the Tennessee Department of Health is to protect, promote, and improve the health and well-being of all residents in the state. For more information on TDH services and programs, visit www.tn.gov/health.